Dietary Modification Clinical Trial
Official title:
Effects of Meat Protein Administration on Body Composition, Strength, Muscle Structure, Immunological and Haematological Markers in Endurance Athletes
The aim of this project is to investigate the potential benefits of combining a new protein beef hydrolysates extract with a regular endurance training programme on (a) body composition (b) performance (c) muscle structure (d) blood markers of health in athletes. As a second objective the investigators will analyse potential differences obtained from the ingestion of the new hydrolysates beef protein extract compared to the ingestion of others commercially available protein sources such as whey and non protein only carbohydrate contrast nutrients.
This investigation involves a 10 weeks randomised, balanced, double blind parallel group
between-subjects design aimed to analyse the effects of combining exercise and a post
exercise nutrition strategy (hydrolysates beef protein, whey protein or a isocaloric only
carbohydrate placebo) on training outcomes, body composition and blood markers after a
period of regular training and feeding intervention. Participants will be divided in
three-treatment groups 1) Hydrolysed meat-protein (Beef); 2) Whey (Whey) and 3) non-protein
iso-energetic placebo (CHO).
Once considered eligible for the study, and after an initial familiarisation period and
baseline tests, participants will be randomly assigned to one of the intervention groups:
Beef; Whey and CHO. Each group will follow a 10-week periodised endurance training
intervention combined with one of the three specific supplementation treatments (Beef, Whey
or CHO). Measurements of blood, body composition, muscle structure and endurance performance
will be determined before and after the training intervention.
Once informed consent and health history have been obtained, after the baseline Assessment
(t1), participants will divided into three similar profile groups, matched by body mass,
age, sex and performance (Vo2max). 1) The Beef protein group (Beef n=12) that will take 20g
of hydrolysates beef protein powder and 250 ml of water 2) The whey group (n=12) will take
20 g of whey intact isolate powder mixed with 250 ml of water 3) the contrast group (CHO
n=12) that will take an iso-energetic non-protein, only carbohydrate (20 f of maltodextrin
plus 250 ml of water) contrast.
Participants: Thirty six participants, recruited from Kent, Medway University Campus, will
take part in the project. After being informed of all risk, discomforts, and benefits
involved, participants will sign a written informed consent regarding their participation.
Intervention Familiarization period: Participants will undertake 1 sessions of
familiarisation with the testing procedure. A qualified conditioning coach will control and
assists participants in order to guarantee a correct understanding of the assessment
procedure (Body composition, vo2max test, muscle thickness, etc). All participants will be
instructed about the appropriate use of the Rate of Perceived Exertion (6-20) Borg scale and
the heart rate monitor to control the load and training intensity during test and training.
Endurance Training: Participants will commit to follow a polarised triphasic
endurance-training model. This model contains three intensity zones calculated as low
intensity [≥ the first ventilatory threshold (VT1), ~ 70% HRmax]; moderate intensity
[between VT1 and respiratory compensation point or ventilatory threshold 2 (VT2), >70 < 90%
HRmax]; and high intensity [>VT2, 90% HRmax] (Esteve-Lanao et al., 2007). Participants will
train 4 to 6 times per week with a total percentage distribution of 75 to 80% at low
intensity; 10% at moderate intensity, and 15 to 10% at high intensity.
Supplementation protocol: Training days: Immediately (<10 min) after com Non-training days:
before breakfast.
Supplements and placebo will be provided in powder form and should be mixed with 250 ml of
plain water at the moment of consumption. Supplements and placebo will looks and tastes
identical.
Thus, a total of one 20g doses will be administered on daily bases. Participants should
ingest a total of 70 doses for a total of 10 weeks of study intervention.
Supplement will be provided in 14 days based by a blind researcher after Participants should
return back the empty bag of the supplement/placebo consumed during the previous 14 days
period.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03586622 -
One Year Home Monitoring and Treatment of IBS Patients
|
N/A | |
Not yet recruiting |
NCT02858557 -
The Effect of Diet on Microbial Profile and Disease Outcomes in Patients With Inflammatory Bowel Diseases
|
N/A | |
Withdrawn |
NCT02863822 -
Study to Evaluate Dietary Modification in Patients With Functional Dyspepsia.
|
N/A | |
Completed |
NCT02589769 -
Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons
|
N/A | |
Completed |
NCT03048487 -
Protein Consumption in Critically Ill Patients
|
||
Completed |
NCT03024983 -
Pasta and Other Durum Wheat-based Products: Effects on Post-prandial Glucose Metabolism
|
N/A | |
Completed |
NCT02480504 -
Effects of a 5:2 Diet on Weight Loss and Cardiovascular Risk Factors in Obesity
|
N/A | |
Recruiting |
NCT02848807 -
Chemotherapy-related Toxicity, Nutritional Status and Quality of Life
|
N/A | |
Completed |
NCT02416284 -
Compliance to the Norwegian Food-Based Dietary Guidelines in Young Females
|
N/A | |
Completed |
NCT01559896 -
Egg Protein Hydrolysate and Vascular Function
|
N/A | |
Terminated |
NCT01329172 -
Nasal Mucin Oral Supplementation Treatment Respiratory Inflammation Using PUFA in Cystic Fibrosis (CF) Patients
|
N/A | |
Completed |
NCT03698929 -
Effect of Dietary Cholesterol on Plasma Lipids
|
N/A | |
Completed |
NCT03942822 -
Chia Supplementation and Non Alcoholic Fatty Liver Disease
|
N/A | |
Completed |
NCT03319836 -
Meeting Protein Targets in Critically Ill Patients
|
||
Completed |
NCT02811276 -
The Impact of a High Protein Diet on Substrate Oxidation and Energy Metabolism
|
N/A | |
Completed |
NCT02940197 -
Comparison of Two Calorie Restricted MediterrAsian Diet on Weight Loss in FTO rs9939609 Overweight Carriers
|
N/A | |
Completed |
NCT02582554 -
Efficacy of Nutrition Risk Screening With NutriSTEP® in Toddlers and Preschoolers
|
N/A | |
Completed |
NCT02574052 -
Medical College Students' Responds to Menu Labeling
|
Phase 3 | |
Completed |
NCT02274220 -
Feeding Study - Effects Post-cardiac Surgery
|
N/A | |
Completed |
NCT02898844 -
Randomized Controlled Experiment of Dieting in Pairs
|
N/A |